Richard Kent Zimmerman, MD, MPH, MA
Dr. Zimmerman is Professor with tenure, University of Pittsburgh School of Medicine, Department of Family Medicine and Clinical Epidemiology with joint appointments in the University of PittsburghClinical and Translational Science Institute, and University of Pittsburgh, Graduate School of Public Health, Department of Behavioral and Community Health Sciences. He has served on the Centers for Disease Control and Prevention Advisory Committee on Immunization Practices as a voting member and as chair of the influenza and adult vaccination working groups.
His research interests focus on vaccine effectiveness and vaccine policy. He is the author of more than 300 publications on immunizations and vaccine-preventable diseases.
Dr. Zimmerman's bibliography can be found through this link: Publications
Research interests include:
Establishing decision rules for COVID-19 outpatients
Test-negative case-control studies of influenza vaccine effectiveness
Randomized cluster trials of measures to increase vaccination rates;
Vaccine modeling using decision analytic and agent-based techniques
Public health bioethics.
Current funded research includes
Outpatient VE for seasonal flu, pandemic flu and RSV in a large, diverse network. The CDC’s outpatient influenza vaccine effectiveness network [PI] https://www.cdc.gov/flu/vaccines-work/us-flu-ve-network.htm#:~:text=The%....
Flu vaccine effectiveness in those hospitalized in a large diverse health system. The CDC’s inpatient influenza vaccine effectiveness network (HAIVEN) [PI]. https://www.cdc.gov/flu/vaccines-work/haiven.html
Analyzing Adult Pneumococcal Vaccination Implementation in the Underserved [NIH, Co-I]. Decisional analytic modeling will address the most cost-effective pneumococcal polysaccharide and conjugate vaccination policies for the US.